Navigation Links
Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Date:10/25/2007

er the process for manufacturing HIF-1a from Genzyme to Sunway, the extent to which HIF-1a is ultimately demonstrated to be safe and effective, Sunway's ability to manufacture sufficient product supply and to distribute the product in a timely and effective manner to support the necessary clinical trials and commercialization, the ability to obtain marketing approval within the territory, the size of the market in the territory for the therapy, actions by governmental authorities related to HIF-1a, and the other risks and uncertainties described in reports filed by Genzyme with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, including without limitation the information under the heading "Risk Factors" in the Management's Discussion and Analysis of Financial Condition and Results of Operations section of the Genzyme Quarterly Report on Form 10-Q for the quarter ending June 30, 2007. Genzyme cautions investors not to place substantial reliance on the forward-looking statements contained in this press release. These statements speak only as of the date of this press release, and Genzyme undertakes no obligation to update or revise the statements.

Genzyme(R) is a registered trademark of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at http://www.genzyme.com and by calling Genzyme's investor information line at 1-800- 905-4369 within the United States or 1-678-999-4572 outside the United States.

Media Contact: Investor Contact:

Bo Piela Patrick Flanigan

617-768-6579 617-768-6563


'/>"/>
SOURCE Genzyme Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Genzyme acquistion of Bone Care approved, significant impact forecast
4. GE, St. Jude to collaborate on visualization technology
5. GE Healthcare, MobileAccess to collaborate on hospital wireless
6. GE Healthcare, Harvard medical school to collaborate on nervous system research
7. Madison, Milwaukee med schools to collaborate on tech transfer
8. EraGen collaborates with Emory University on HIV detection system
9. The Genesis of Gendicine: The Story Behind the First Gene Therapy
10. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
11. TomoTherapy opens technical training center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... September 02, 2014 The Little Company ... Chicagoland, constructed a new 290,000 square-foot West Pavilion patient ... Lockers from Scranton Products for the nurse’s lounge ... Little Company of Mary Hospital’s $180 million, ... 2014 with the connection of the West Pavilion tower ...
(Date:9/2/2014)... for detailed studies of what happens on the surface ... among other applications. A group of researchers from Lund ... membranes form across a large number of vertical nanowires, ... interior of a cell and its surroundings takes place ... layer that holds the cell together and that largely ...
(Date:9/2/2014)... -- Technology Applications International Corporation (the "Company" or "NUUU")(OTC BB: ... Inc. has signed an additional exclusive licensing agreement with ... Johnson Space Center in Houston , ... Charles J. Scimeca , NUUU,s ... latest, exclusive agreement with NASA. In addition to our ...
(Date:9/2/2014)... Sept. 2, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY ... and Chief Executive Officer, will present at the Rodman & ... New York on Tuesday, Sept. 9, 2014 ... archived webcast of the presentation will be accessible by visiting ... Events" section. About Oncothyreon ...
Breaking Biology Technology:Tufftec® Lockers from Scranton Products Selected by Little Company of Mary Hospital Near Chicago to Create an Uplifting Environment 2Tufftec® Lockers from Scranton Products Selected by Little Company of Mary Hospital Near Chicago to Create an Uplifting Environment 3Nano-forests to reveal secrets of cells 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3
... PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 9, Shire plc ... has received Paragraph IV Notice letters from Barr Laboratories, ... February 2009 respectively,advising in each case of the filing ... version of 500mg, 750mg and 1gm FOSRENOL(R),(lanthanum carbonate). , ...
... 9 Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) management,s presentation at the ... Eastern will be,webcast live with slides at http://www.celltherapeutics.com . , ... Waldorf-Astoria,Hotel, and will also be available for replay after the presentation. , , ... BIO CEO & ...
... Clinics of Excellence, LLC, the nation,s only physician-driven ... its 62nd comprehensive Evidence-Based Treatment Protocol covering 11 ... 4th Annual Community Oncology Conference today. "Our 200+ ... to launch the protocols across its network in ...
Cached Biology Technology:Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2Cancer Clinics of Excellence (CCE) Releases 62nd Evidence-Based Treatment Protocol 2
(Date:9/2/2014)... which counts with the participation of the University of ... that took place in the Iberian Peninsula around the ... of atmospheric dust coming from the Sahara increased. The ... in an Alpine lake in Sierra Nevada (Granada) , ... , is based on the sedimentation of atmospheric dust ...
(Date:9/2/2014)... to prevent Type 2 diabetes, don,t get your hopes up. ... The FASEB Journal , suggests that you don,t ... study compared genetically identical twins-one heavier and one leaner-and found ... those related to Type 2 diabetes, were found in both ... the onset of this type of diabetes is largely influenced ...
(Date:9/2/2014)... birds, that migrate by night tend to fly faster ... their destinations. This seasonal difference in flight speed is ... flights, says researcher Cecilia Nilsson of Lund University in ... . , Nilsson, in a group led by ... over three years the speed by which birds flew ...
Breaking Biology News(10 mins):Scientists obtain new data on the weather 10,000 years ago from sediments of a lake in Sierra Nevada 2What you eat and not just the number of calories, is a significant factor in diabetes risk 2Migrating birds sprint in spring, but take things easy in autumn 2
... Georgia Tech City and Regional Planning study on climate ... Science and Technology , shows that "smart growth" combined ... cities, carbon dioxide (CO2) emissions the principal driver ... According to Brian Stone, associate professor of City and ...
... out one gene that contributes to insulin resistance appears ... with obesity, researchers say. Cardiovascular disease is the ... Georgia researchers trying to understand why have knocked out ... mice that get diabetes. "Even before you have ...
... COLUMBIA, Mo. More than 20 million tons of plastic ... new University of Missouri study suggest that some of the ... renewable plastic made from plants. Reducing the carbon footprint and ... also provide an additional cash crop for farmers. "Making ...
Cached Biology News:Reducing CO2 through technology and smart growth 2Decreasing insulin resistance prevents obesity-related cardiovascular damage 2Decreasing insulin resistance prevents obesity-related cardiovascular damage 3'Green' plastics could help reduce carbon footprint 2
Anti-Human Factor XI Purified (Polyclonal) (sheep IgG)...
...
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Biology Products: